StonvexLoading…
StonvexStonvexStonvexCore line items from ORCL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-02-28 | Q4 2025 2025-11-30 | Q3 2025 2025-08-31 | Annual 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $48.17B | $30.98B | $14.93B | $57.40B |
Operating Income | $14.47B | $9.01B | $4.28B | $17.68B |
Net Income | $12.78B | $9.06B | $2.93B | $12.44B |
EPS (Diluted) | $4.38 | $3.11 | $1.01 | $4.34 |
Total Assets | $245.24B | $204.98B | $180.45B | $168.36B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $38.45B | $19.24B | $10.45B | $10.79B |
Free Cash Flow OCF − CapEx | $-21.81B | $-10.33B | $-362.00M | $-394.00M |
Shares Outstanding | 2.88B | 2.87B | 2.84B | 2.81B |